NCT00805129
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Clinical trial condition
Metastatic Transitional Cell Carcinoma
Explore clinical trials studying Metastatic Transitional Cell Carcinoma. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Metastatic Transitional Cell Carcinoma trial results
Active, Not Recruiting
Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations
NCT03047213
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +18 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Keck Medical Center of USC Pasadena Pasadena, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States